Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Renal cell carcinoma

M Davis1

  • 1Oncology/Biotech Division, Schering Laboratories, Schering-Plough Corporation, Kenilworth, NJ.

Seminars in Oncology Nursing
|November 1, 1993
PubMed
Summary
This summary is machine-generated.

Metastatic renal cell cancer lacks effective traditional treatments. Advances in immunotherapy and molecular genetics offer new hope, emphasizing clinical trials and quality of life for advanced kidney cancer patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

LOH and mutation analysis of CDKN2 in primary human ovarian cancers.

International journal of cancer·1995
Same author

Peptidyl alpha-ketoheterocyclic inhibitors of human neutrophil elastase. 3. In vitro and in vivo potency of a series of peptidyl alpha-ketobenzoxazoles.

Journal of medicinal chemistry·1995
Same author

Myositis and fasciitis associated with group A beta hemolytic streptococcal infections: development of a rabbit model.

The Journal of laboratory and clinical medicine·1995
Same author

Esophago-airway fistula in AIDS.

The Annals of thoracic surgery·1995
Same author

Lesions of the central nucleus of the amygdala block conditioned excitation, but not conditioned inhibition of fear as measured with the fear-potentiated startle effect.

Behavioral neuroscience·1995
Same author

Habituation of prepulse inhibition of the startle reflex using an auditory prepulse close to background noise.

Behavioral neuroscience·1995
Same journal

Health-Related Quality of Life in Cancer Cachexia: Validation of the Turkish Version of the Functional Assessment of Anorexia/Cachexia Therapy (FAACT).

Seminars in oncology nursing·2026
Same journal

A Dyadic Study of Lived Experiences of Family Stress, Emotional Distress and Family Resilience Among Women With Cancer During Pregnancy and Their Partners.

Seminars in oncology nursing·2026
Same journal

Rapid Reduction in Cancer Worry Through a Mindfulness-based Coping Programme: Evidence from a Randomised Trial with Women Awaiting Biopsy Results.

Seminars in oncology nursing·2026
Same journal

Refining Genomic Integration in Hereditary Breast Cancer: Reflections on Clinical and Nursing Implications.

Seminars in oncology nursing·2026
Same journal

Bridge Symptoms Between Symptom Clusters in Children with Acute Lymphoblastic Leukemia During Maintenance Therapy: A Network Analysis.

Seminars in oncology nursing·2026
Same journal

Journey Mapping of the Patient Experience from Diagnosis to End of Life in Lung Cancer: A Qualitative Meta-Synthesis.

Seminars in oncology nursing·2026
See all related articles

Area of Science:

  • Oncology
  • Immunology
  • Molecular Genetics

Background:

  • Complete surgical resection offers cure for localized renal cell cancer.
  • Metastatic renal cell cancer is challenging to manage with traditional therapies like surgery, chemotherapy, or radiation.
  • Recent advancements in immunobiology and molecular genetics have spurred new treatment strategies.

Purpose of the Study:

  • To explore novel therapeutic regimens for metastatic renal cell cancer.
  • To highlight the importance of quality of life and symptom management in advanced disease.
  • To encourage participation in clinical trials for patients with limited effective treatment options.

Main Methods:

  • Review of current understanding in immunobiology and molecular genetics.

Related Experiment Videos

  • Analysis of the efficacy of traditional treatment modalities.
  • Emphasis on patient-centered care, including symptom control and psychosocial support.

    • Main Results:

    • Traditional therapies are largely ineffective for metastatic renal cell cancer.
    • Biologic response modifiers and novel approaches show promise.
    • Quality of life, symptom management, and clinical trial participation are crucial.

    Conclusions:

    • Metastatic renal cell cancer requires innovative treatment approaches beyond traditional methods.
    • Focusing on quality of life and palliative care is essential for patients with advanced disease.
    • Clinical trials offer the best opportunity for eligible patients to access novel therapies.